|
Concomitant medical product(s): (b)(6) 2019: dyshidrotic lidex ointment (eczema).(b)(6) 2019: breo 100 re: asthma.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The events of seroma and capsular contracture are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: seroma; capsular contracture, baker grade unknown.
|
|
Documentation received from patient representative noting that approximately one month post implant the following events were experienced: serous cloudy drainage; via ultrasound moderate effusion surrounding patient¿s silicone implant was noted; fluid was seen surrounding nearly the entire implant; us breast guidance needle placement yielded 180 ml of cloudy yellow fluid, left breast drain has continued.Drainage, central breast on both sides reveal a dermatitis with fewer vesicles, less weeping, and a drying rash, left breast is consistent with early post infection capsular contraction at this time; left breast tightness; firmness, medial breast induration; left breast firm but softening, and left lump.The following events have been deemed not related to the device: acute bronchitis/wheezing (cough, fever, chest congestion, fatigue), insomnia, decreased exercise tolerance, asthma, weight gain, fatigue, and anxiety.Affected side is left.The device remains implanted.
|